Menu
PTAB Blog
Biosimilars Blog
RF 360

Publications

Precise. Insightful. Skilled.
Search Publications
View All

Publications

AI in Augmented Reality and Entertainment
AI in Augmented Reality and Entertainment

Associate Jennifer B. Maisel authored a chapter titled “AI in Augmented Reality and Entertainment” published in the American Bar Association (ABA) new book, The Law of Artificial Intelligence and Smart Machines. The book provides an in-depth…
More

DOJ Invokes Flawed Market Definition To Block Print Deal

Quad/Graphics Inc.[1] and LSC Communications Inc.[2] recently announced the termination of their $1.5 billion deal that would have seen Quad acquire LSC. The companies made this decision after the U.S. Department of Justice filed a…
More

Biosimilars Blog

BiosimilarsIP.com features articles, updates, and analysis on regulatory issues, legal decisions, and other news related to biologics and biosimilars under the Biologics Price Competition and Innovation Act (BPCIA). The posts, authored and edited by attorneys in the firm’s Biologics and Biosimilars practice group, track regulatory issues and events, provide analysis of legal decisions from federal courts and from the Patent Trial and Appeal Board, and offer updates on current news and events related to biologics and biosimilars. Our team understands the manufacturing, regulatory, and legal requirements of the field, and has the experience and the technical knowledge to handle the most sophisticated matters, including issues related to regulatory approval, securing patent rights, counseling and opinions, post-grant challenges, and asserting or defending against patents in litigation. To learn more, please visit www.BiosimilarsIP.com.

Visit Blog
PTAB Blog

Authored and edited by attorneys in the firm’s Post-Grant Trial practice group, PTABLaw.com provides updates, articles, and analysis about the Patent Trial and Appeal Board (PTAB), the Court of Appeals for the Federal Circuit, and the American Invents Act.  Our group has considerable experience handling inter partes review (IPR), covered business method (CBM) review, and post-grant review (PGR) proceedings before the PTAB.  Our depth of knowledge and expertise with handling matters before the PTAB is unique, as many of the attorneys in our group have substantial experience in handling interference proceedings and reexaminations, and in prosecuting applications before the Office, as well as extensive litigation experience in the federal courts. To learn more, please visit www.PTABLaw.com.

Visit Blog